Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker Diabetic Fatty rat)

This study was performed to assess the effect of chronic low-dose sitagliptin, a dipeptidyl peptidase 4 inhibitor, on metabolic profile and on renal lesions aggravation in a rat model of type-2 diabetic nephropathy, the Zucker Diabetic Fatty (ZDF) rat. Diabetic and obese ZDF (fa/fa) rats and their c...

ver descrição completa

Detalhes bibliográficos
Autor principal: Mega, C. (author)
Outros Autores: Teixeira de Lemos, E. (author), Vala, Helena (author), Fernandes, R. (author), Oliveira, J. (author), Mascarenhas-Melo, F. (author), Teixeira, F. (author), Reis, F. (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
type 2 diabetic nephropathy
sitagliptin
dysmetabolism
renal lesion
ZDF rat
Texto completo:http://hdl.handle.net/10400.19/1413
País:Portugal
Oai:oai:repositorio.ipv.pt:10400.19/1413

Texto Completo

http://hdl.handle.net/10400.19/1413

Registros relacionados